May 24, 2017 13:23 pm UTC| Business
JERSEY CITY, N.J., May 24, 2017 -- SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company delivering innovative anti-infective therapies for difficult-to-treat and often life-threatening infections, today announced eight...
May 24, 2017 13:23 pm UTC| Business
JERSEY CITY, N.J., May 24, 2017 -- SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company delivering innovative anti-infective therapies for difficult-to-treat and often life-threatening infections, today announced eight...
May 24, 2017 13:23 pm UTC| Business
JERSEY CITY, N.J., May 24, 2017 -- SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company delivering innovative anti-infective therapies for difficult-to-treat and often life-threatening infections, today announced eight...
May 24, 2017 13:23 pm UTC| Business
JERSEY CITY, N.J., May 24, 2017 -- SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company delivering innovative anti-infective therapies for difficult-to-treat and often life-threatening infections, today announced eight...
May 24, 2017 13:23 pm UTC| Business
JERSEY CITY, N.J., May 24, 2017 -- SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company delivering innovative anti-infective therapies for difficult-to-treat and often life-threatening infections, today announced eight...
May 24, 2017 13:23 pm UTC| Business
JERSEY CITY, N.J., May 24, 2017 -- SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company delivering innovative anti-infective therapies for difficult-to-treat and often life-threatening infections, today announced eight...
May 24, 2017 13:23 pm UTC| Business
JERSEY CITY, N.J., May 24, 2017 -- SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company delivering innovative anti-infective therapies for difficult-to-treat and often life-threatening infections, today announced eight...